PFIZER · Pfizer Limited · Financials
Volume · Nov 13
5393
Avg daily vol (14 sessions)
7538
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
25.2B
+10.4%
FY2026
Net Income
7.22B
-5.9%
FY2026
Operating Cash Flow
9.68B
+46.7%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| INR | 26.54B | 25.2B | 22.81B | 21.93B | 24.25B | 26.11B | 22.39B | 21.52B | 20.82B | 19.8B |
| INR | 577.1M | 577.3M | 607.9M | 622.8M | 1.06B | 1.15B | 1.09B | 1.03B | 713.9M | 662.5M |
| INR | 89.1M | 94.8M | 84.1M | 154.1M | 133.9M | 104.9M | 151.1M | 108.5M | 12.9M | 4.2M |
| INR | 11.6B | 9.76B | 10.16B | 7.46B | 8.24B | 7.73B | 6.69B | 6.42B | 6.6B | 5.48B |
| INR | 3.01B | 2.53B | 2.48B | 1.95B | 2B | 1.6B | 1.71B | 1.33B | 2.31B | 1.88B |
| INR | 8.59B | 7.22B | 7.68B | 5.51B | 6.24B | 6.13B | 4.98B | 5.09B | 0 | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 15.52B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.